Trupanion (TRUP) Projected to Post Quarterly Earnings on Thursday

Trupanion (NASDAQ:TRUP) will likely be releasing its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect Trupanion to post earnings of $0.06 per share and revenue of $361.5750 million for the quarter. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS.Interested persons may visit the the company’s upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Thursday, November 6, 2025 at 4:30 PM ET.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings results on Thursday, August 7th. The financial services provider reported $0.22 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.25. Trupanion had a return on equity of 3.31% and a net margin of 0.81%.The business had revenue of $353.56 million for the quarter, compared to the consensus estimate of $346.73 million. During the same period in the prior year, the business earned ($0.14) EPS. The firm’s revenue for the quarter was up 12.3% on a year-over-year basis. On average, analysts expect Trupanion to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Trupanion Stock Performance

NASDAQ TRUP opened at $39.39 on Wednesday. The company has a fifty day moving average price of $43.34 and a 200-day moving average price of $46.37. Trupanion has a 1 year low of $31.00 and a 1 year high of $57.88. The firm has a market cap of $1.69 billion, a price-to-earnings ratio of 151.51 and a beta of 1.83. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.69 and a quick ratio of 1.69.

Insiders Place Their Bets

In other Trupanion news, Director Darryl Rawlings sold 30,369 shares of the business’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $44.70, for a total transaction of $1,357,494.30. Following the completion of the transaction, the director owned 1,413,281 shares in the company, valued at $63,173,660.70. The trade was a 2.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Margaret Tooth sold 8,884 shares of the company’s stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $43.73, for a total value of $388,497.32. Following the transaction, the chief executive officer directly owned 141,345 shares in the company, valued at approximately $6,181,016.85. This represents a 5.91% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 70,645 shares of company stock valued at $3,128,119 over the last 90 days. Insiders own 5.42% of the company’s stock.

Institutional Trading of Trupanion

Several institutional investors and hedge funds have recently made changes to their positions in TRUP. Tidal Investments LLC purchased a new stake in Trupanion in the 2nd quarter valued at about $212,000. Brevan Howard Capital Management LP bought a new position in Trupanion in the second quarter worth approximately $236,000. Gabelli Funds LLC purchased a new position in Trupanion during the 2nd quarter worth $249,000. Tower Research Capital LLC TRC increased its holdings in Trupanion by 490.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,754 shares of the financial services provider’s stock worth $263,000 after purchasing an additional 3,949 shares during the period. Finally, Nebula Research & Development LLC bought a new stake in Trupanion during the 2nd quarter valued at $266,000.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on TRUP. Weiss Ratings reissued a “hold (c-)” rating on shares of Trupanion in a research note on Wednesday, October 8th. Stifel Nicolaus upped their price target on Trupanion from $41.00 to $45.00 and gave the stock a “hold” rating in a research note on Friday, August 8th. Cantor Fitzgerald upgraded Trupanion to a “hold” rating in a research note on Wednesday, August 13th. Finally, Piper Sandler lifted their target price on Trupanion from $62.00 to $67.00 and gave the company an “overweight” rating in a research report on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $54.75.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.